| For: | Wang GY, Zhang XY, Wang CJ, Guan YF. Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies. World J Gastroenterol 2023; 29(1): 75-95 [PMID: 36683713 DOI: 10.3748/wjg.v29.i1.75] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i1/75.htm |
| Number | Citing Articles |
| 1 |
Saeedeh Zare Jalise, Sina Habibi, Fateme Alizadeh, Fateme Heidari, Leyla Fath-Bayati. Three Dimensional Biomimetic Liver Models to Reconstitute Metabolic Dysfunction-Associated Steatohepatitis (MASH) In Vitro: Hope and Reality. Journal of Clinical and Experimental Hepatology 2026; 16(5) doi: 10.1016/j.jceh.2026.103599
|
| 2 |
M. Soto-Catalán, L. Opazo-Ríos, C. Espadas, M. Romero-Cote, I. Lázaro, J. A. Moreno, C. Gómez-Guerrero, J. Egido, S. Mas-Fontao. SOCS1-based therapeutic peptides improve liver disease and metabolic dysfunction in obesity and diabetes. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-46312-4
|
| 3 |
Yongyi Liang, Shaojun Qiu, Youwen Zou, Lianxiang Luo. Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies. Phytomedicine 2024; 122 doi: 10.1016/j.phymed.2023.155134
|
| 4 |
Ruyan Yuan, Jiamin Zhang, Yamei Huang, Yiyang Meng, Siyan Liu, Wanqing Yang, Xinru Zhang, Mengyu Yang, Menglei Liang, Yipei Huang, Chang Liu, Zhaoxia Cheng, Xiaotian Li, Cong Wang, Jundong Yao, Xiao Zhang, Dongdong Zhang, Ying Zhao, Fenfen Li, Lei Wang. Scavenger Receptor
Class B Type 1 Mediated Transport
Enables Delivery Across Capillarized Liver Sinusoids in Metabolic
Dysfunction-Associated Steatohepatitis. ACS Nano 2026; 20(37) doi: 10.1021/acsnano.6c05500
|
| 5 |
Shuangnv Lin, Meng Wang, Jing Pan, Weisong Dong, Yincai Ye, Zuoting Xie, Wenjing Xue. Perillyl alcohol alleviates liver fibrosis by promoting hepatic stellate cell ferroptosis and inhibiting macrophage recruitment. Chemico-Biological Interactions 2026; 435 doi: 10.1016/j.cbi.2026.112164
|
| 6 |
Joseph Tawai, Kairan Zhou, Jing Xiong. Lipotoxicity in MAFLD/MASH: cellular mechanisms and targetable nodes. Targetome 2026; 2(5) doi: 10.48130/targetome-0026-0047
|
| 7 |
Amjad Mahmood Qadir, Rebaz Anwar Omer. Hypothyroidism and Metabolic Dysfunction–Associated Steatotic Liver Disease: Mechanisms, Clinical Links, and Therapeutic Implications. Current Obesity Reports 2026; 15(1) doi: 10.1007/s13679-026-00764-x
|
| 8 |
Jingwen Xu, Yue Li, Guangyan Wang, Dapeng Chen, Chenxue Hou, Rui Wang, Wenhui Dong, Lei Sun, Kun Yang, Jinjie Duan, Guangyin Pu, Xiaoyu Zhao, Rong Ai, Wenjing Xiu, Qi Wang, Chunjiong Wang. Impaired mitochondrial degradation of CHCHD2 promotes metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma by upregulating VEGFA. Oncogene 2025; 44(20) doi: 10.1038/s41388-025-03321-3
|
| 9 |
Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; doi: 10.1007/978-981-97-9519-2_10
|
| 10 |
Fenfen Li, Ruyan Yuan, Jiamin Zhang, Bing Su, Xiaolong Qi. Advances in nanotechnology for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease. Asian Journal of Pharmaceutical Sciences 2025; 20(2) doi: 10.1016/j.ajps.2025.101025
|
| 11 |
Noha M. Gamil, Habiba A. Elsayed, Esraa T. Salah, Heba A. Mostafa, Riham A. El-Shiekh, Heba R. Ghaiad, Hebatollah E. Eitah. Decoding the mechanistic basis of liver–muscle communication in health and disease. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; 399(8) doi: 10.1007/s00210-026-05015-3
|
| 12 |
Zhichao Lang, Suhui Yu, Yuhang Hu, Qiqi Tao, Jingnan Zhang, Haoyue Wang, Lei Zheng, Zhixian Yu, Jianjian Zheng. Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11. Phytomedicine 2023; 118 doi: 10.1016/j.phymed.2023.154950
|
| 13 |
Lucia Longhitano, Alfio Distefano, Nicolò Musso, Paolo Bonacci, Laura Orlando, Sebastiano Giallongo, Daniele Tibullo, Simona Denaro, Giuseppe Lazzarino, Jessica Ferrigno, Anna Nicolosi, Amer M. Alanazi, Federico Salomone, Emanuela Tropea, Ignazio Alberto Barbagallo, Vincenzo Bramanti, Giovanni Li Volti, Giacomo Lazzarino, Daniele Torella, Angela Maria Amorini. (+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-04880-x
|
| 14 |
Susana Bernal, Ignacio Prieto, María Kavanagh, Isabel Herrero del Real, Sara La Manna, Iolanda Lázaro, Hernán Quiceno, Laura López-Sanz, Belén Picatoste, M. Pilar Valdecantos, Sebastián Mas-Fontao, Aleix Sala-Vila, Ángela M. Valverde, Daniela Marasco, Jesús Egido, Carmen Gómez-Guerrero. Development of SOCS1 mimetics as novel approach to harmonize inflammation, oxidative stress, and fibrogenesis in metabolic dysfunction-associated steatotic liver disease. Redox Biology 2025; 84 doi: 10.1016/j.redox.2025.103670
|